# Prometheus

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/prometheus
Canonical HTML page: https://getbiobrief.com/entity/prometheus

## Recent coverage (1 stories)

### $12B Bet on AGI Drug Design: Bezos’s Prometheus Targets Biotech Manufacturing
2026-06-12 02:52:28 · Sentiment: Very Bullish · Impact: 9/10 · Sources: 2

Prometheus's $12B raise envisions an artificial general engineer that can design drug compounds autonomously, potentially cutting years from pharmaceutical R&D. The startup's biotech roots via co-founder Vik Bajaj of Verily add credibility.
Full story: https://getbiobrief.com/story/bio-prometheus-12b-drugs

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.